Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546141 - 546160 out of 553712 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L02BA03) fulvestrant (adm: P) | FASLODEX 50MG/ML INJ 5ML SYRINGE | 2X5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L02BA03) fulvestrant (adm: P) | FASLODEX 50MG/ML INJ 5ML SYRINGE | 2X5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L02BA03) fulvestrant (adm: P) | FULVESTRANT 50MG/ML INJ,SYRINGE,5ML | 2x5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L02BA03) fulvestrant (adm: P) | FULVESTRANT 50MG/ML INJ,SYRINGE,5ML | 2x5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L02BA04) elacestrant | ORSERDU 345MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | StemlineTherapeutics,Inc. |
| USA | (L02BA04) elacestrant | ORSERDU 345MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | StemlineTherapeutics,Inc. |
| USA | (L02BA04) elacestrant | ORSERDU 86MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | StemlineTherapeutics,Inc. |
| USA | (L02BA04) elacestrant | ORSERDU 86MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | StemlineTherapeutics,Inc. |
| USA | (L02BB02) nilutamide (adm: O) | NILANDRON 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmdipharmLimited |
| USA | (L02BB02) nilutamide (adm: O) | NILANDRON 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmdipharmLimited |
| USA | (L02BB02) nilutamide (adm: O) | NILUTAMIDE 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L02BB02) nilutamide (adm: O) | NILUTAMIDE 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L02BB03) bicalutamide (adm: O) | CASODEX 50MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ANIPAcquisitionCompany,d/b/aANIPharmaceuticals,Inc. |
| USA | (L02BB03) bicalutamide (adm: O) | CASODEX 50MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ANIPAcquisitionCompany,d/b/aANIPharmaceuticals,Inc. |
| USA | (L02BB04) enzalutamide (adm: O) | XTANDI 40MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | AstellasPharmaU.S.,Inc. |
| USA | (L02BB04) enzalutamide (adm: O) | XTANDI 40MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | AstellasPharmaU.S.,Inc. |
| USA | (L02BB04) enzalutamide (adm: O) | XTANDI 80MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | AstellasPharmaU.S.,Inc. |
| USA | (L02BB05) apalutamide (adm: O) | ERLEADA 240MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L02BB05) apalutamide (adm: O) | ERLEADA 240MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L02BB05) apalutamide (adm: O) | ERLEADA 60MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
Pages
